 | • レポートコード：GIR-2104Z07398 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、高血圧治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。高血圧治療薬の種類別市場規模（カルシウムチャネル遮断薬、利尿薬、ベータ遮断薬血管拡張薬、アンジオテンシン変換酵素阻害薬、アルファ遮断薬、アンジオテンシン受容体遮断薬、レニン阻害薬）、用途別市場規模（病院、私立クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・高血圧治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Lupin Limited、Novartis AG、Daiichi - Sankyo、Pfizer Inc、Ranbaxy Laboratories Limited、Sanofi S.A、AstraZeneca Plc、Johnson & Johnson Ltd、Boehringer Ingelheim、Merck & Co. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：カルシウムチャネル遮断薬、利尿薬、ベータ遮断薬血管拡張薬、アンジオテンシン変換酵素阻害薬、アルファ遮断薬、アンジオテンシン受容体遮断薬、レニン阻害薬 ・用途別分析2016年-2026年：病院、私立クリニック、その他 ・高血圧治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・高血圧治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・高血圧治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・高血圧治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・高血圧治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Hypertension Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Hypertension Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Hypertension Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Hypertension Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors
Market segment by Application can be divided into
Hospital
Private Clinic
Others
The key market players for global Hypertension Drug market are listed below:
Lupin Limited
Novartis AG
Daiichi – Sankyo
Pfizer Inc
Ranbaxy Laboratories Limited
Sanofi S.A
AstraZeneca Plc
Johnson & Johnson Ltd
Boehringer Ingelheim
Merck & Co.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Hypertension Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hypertension Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Calcium Channel Blockers
1.2.3 Diuretics
1.2.4 Beta Blockers Vasodilators
1.2.5 Angiotensin Converting Enzyme Inhibitors
1.2.6 Alpha Blockers
1.2.7 Angiotensin Receptor Blockers
1.2.8 Renin Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Hypertension Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Private Clinic
1.3.4 Others
1.4 Global Hypertension Drug Market Size & Forecast
1.4.1 Global Hypertension Drug Sales in Value (2016-2026))
1.4.2 Global Hypertension Drug Sales in Volume (2016-2026)
1.4.3 Global Hypertension Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Hypertension Drug Production Capacity Analysis
1.5.1 Global Hypertension Drug Total Production Capacity (2016-2026)
1.5.2 Global Hypertension Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hypertension Drug Market Drivers
1.6.2 Hypertension Drug Market Restraints
1.6.3 Hypertension Drug Trends Analysis
2 Manufacturers Profiles
2.1 Lupin Limited
2.1.1 Lupin Limited Details
2.1.2 Lupin Limited Major Business
2.1.3 Lupin Limited Hypertension Drug Product and Services
2.1.4 Lupin Limited Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG Hypertension Drug Product and Services
2.2.4 Novartis AG Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Daiichi – Sankyo
2.3.1 Daiichi – Sankyo Details
2.3.2 Daiichi – Sankyo Major Business
2.3.3 Daiichi – Sankyo Hypertension Drug Product and Services
2.3.4 Daiichi – Sankyo Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Pfizer Inc
2.4.1 Pfizer Inc Details
2.4.2 Pfizer Inc Major Business
2.4.3 Pfizer Inc Hypertension Drug Product and Services
2.4.4 Pfizer Inc Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Ranbaxy Laboratories Limited
2.5.1 Ranbaxy Laboratories Limited Details
2.5.2 Ranbaxy Laboratories Limited Major Business
2.5.3 Ranbaxy Laboratories Limited Hypertension Drug Product and Services
2.5.4 Ranbaxy Laboratories Limited Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Sanofi S.A
2.6.1 Sanofi S.A Details
2.6.2 Sanofi S.A Major Business
2.6.3 Sanofi S.A Hypertension Drug Product and Services
2.6.4 Sanofi S.A Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 AstraZeneca Plc
2.7.1 AstraZeneca Plc Details
2.7.2 AstraZeneca Plc Major Business
2.7.3 AstraZeneca Plc Hypertension Drug Product and Services
2.7.4 AstraZeneca Plc Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Johnson & Johnson Ltd
2.8.1 Johnson & Johnson Ltd Details
2.8.2 Johnson & Johnson Ltd Major Business
2.8.3 Johnson & Johnson Ltd Hypertension Drug Product and Services
2.8.4 Johnson & Johnson Ltd Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Hypertension Drug Product and Services
2.9.4 Boehringer Ingelheim Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Merck & Co.
2.10.1 Merck & Co. Details
2.10.2 Merck & Co. Major Business
2.10.3 Merck & Co. Hypertension Drug Product and Services
2.10.4 Merck & Co. Hypertension Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Hypertension Drug Sales by Manufacturer
3.1 Global Hypertension Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Hypertension Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Hypertension Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Hypertension Drug Manufacturer Market Share
3.4.2 Top 6 Hypertension Drug Manufacturer Market Share
3.5 Global Hypertension Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Hypertension Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hypertension Drug Market Size by Region
4.1.1 Global Hypertension Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Hypertension Drug Revenue by Region (2016-2026)
4.2 North America Hypertension Drug Revenue (2016-2026)
4.3 Europe Hypertension Drug Revenue (2016-2026)
4.4 Asia-Pacific Hypertension Drug Revenue (2016-2026)
4.5 South America Hypertension Drug Revenue (2016-2026)
4.6 Middle East and Africa Hypertension Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Hypertension Drug Sales in Volume by Type (2016-2026)
5.2 Global Hypertension Drug Revenue by Type (2016-2026)
5.3 Global Hypertension Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Hypertension Drug Sales in Volume by Application (2016-2026)
6.2 Global Hypertension Drug Revenue by Application (2016-2026)
6.3 Global Hypertension Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Hypertension Drug Sales by Type (2016-2026)
7.2 North America Hypertension Drug Sales by Application (2016-2026)
7.3 North America Hypertension Drug Market Size by Country
7.3.1 North America Hypertension Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Hypertension Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Hypertension Drug Sales by Type (2016-2026)
8.2 Europe Hypertension Drug Sales by Application (2016-2026)
8.3 Europe Hypertension Drug Market Size by Country
8.3.1 Europe Hypertension Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Hypertension Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Hypertension Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Hypertension Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Hypertension Drug Market Size by Region
9.3.1 Asia-Pacific Hypertension Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Hypertension Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Hypertension Drug Sales by Type (2016-2026)
10.2 South America Hypertension Drug Sales by Application (2016-2026)
10.3 South America Hypertension Drug Market Size by Country
10.3.1 South America Hypertension Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Hypertension Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hypertension Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Hypertension Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Hypertension Drug Market Size by Country
11.3.1 Middle East & Africa Hypertension Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Hypertension Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Hypertension Drug Typical Distributors
12.3 Hypertension Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Hypertension Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Hypertension Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Lupin Limited Basic Information, Manufacturing Base and Competitors
Table 4. Lupin Limited Major Business
Table 5. Lupin Limited Hypertension Drug Product and Services
Table 6. Lupin Limited Hypertension Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 8. Novartis AG Major Business
Table 9. Novartis AG Hypertension Drug Product and Services
Table 10. Novartis AG Hypertension Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Daiichi - Sankyo Basic Information, Manufacturing Base and Competitors
Table 12. Daiichi - Sankyo Major Business
Table 13. Daiichi - Sankyo Hypertension Drug Product and Services
Table 14. Daiichi - Sankyo Hypertension Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Inc Major Business
Table 17. Pfizer Inc Hypertension Drug Product and Services
Table 18. Pfizer Inc Hypertension Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Ranbaxy Laboratories Limited Basic Information, Manufacturing Base and Competitors
Table 20. Ranbaxy Laboratories Limited Major Business
Table 21. Ranbaxy Laboratories Limited Hypertension Drug Product and Services
Table 22. Ranbaxy Laboratories Limited Hypertension Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sanofi S.A Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi S.A Major Business
Table 25. Sanofi S.A Hypertension Drug Product and Services
Table 26. Sanofi S.A Hypertension Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 28. AstraZeneca Plc Major Business
Table 29. AstraZeneca Plc Hypertension Drug Product and Services
Table 30. AstraZeneca Plc Hypertension Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Johnson & Johnson Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Johnson & Johnson Ltd Major Business
Table 33. Johnson & Johnson Ltd Hypertension Drug Product and Services
Table 34. Johnson & Johnson Ltd Hypertension Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 36. Boehringer Ingelheim Major Business
Table 37. Boehringer Ingelheim Hypertension Drug Product and Services
Table 38. Boehringer Ingelheim Hypertension Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 40. Merck & Co. Major Business
Table 41. Merck & Co. Hypertension Drug Product and Services
Table 42. Merck & Co. Hypertension Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Hypertension Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Hypertension Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Hypertension Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Hypertension Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Hypertension Drug Production Site of Key Manufacturer
Table 48. Global Hypertension Drug Sales by Region (2016-2021e) & (K Units)
Table 49. Global Hypertension Drug Sales by Region (2021-2026) & (K Units)
Table 50. Global Hypertension Drug Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Hypertension Drug Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Hypertension Drug Sales by Type (2016-2021e) & (K Units)
Table 53. Global Hypertension Drug Sales by Type (2021-2026) & (K Units)
Table 54. Global Hypertension Drug Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Hypertension Drug Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Hypertension Drug Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global Hypertension Drug Price by Type (2021-2026) & (USD/Unit)
Table 58. Global Hypertension Drug Sales by Application (2016-2021e) & (K Units)
Table 59. Global Hypertension Drug Sales by Application (2021-2026) & (K Units)
Table 60. Global Hypertension Drug Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Hypertension Drug Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Hypertension Drug Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global Hypertension Drug Price by Application (2021-2026) & (USD/Unit)
Table 64. North America Hypertension Drug Sales by Country (2016-2021e) & (K Units)
Table 65. North America Hypertension Drug Sales by Country (2021-2026) & (K Units)
Table 66. North America Hypertension Drug Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Hypertension Drug Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Hypertension Drug Sales by Type (2016-2021e) & (K Units)
Table 69. North America Hypertension Drug Sales by Type (2021-2026) & (K Units)
Table 70. North America Hypertension Drug Sales by Application (2016-2021e) & (K Units)
Table 71. North America Hypertension Drug Sales by Application (2021-2026) & (K Units)
Table 72. Europe Hypertension Drug Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Hypertension Drug Sales by Country (2021-2026) & (K Units)
Table 74. Europe Hypertension Drug Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Hypertension Drug Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Hypertension Drug Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Hypertension Drug Sales by Type (2021-2026) & (K Units)
Table 78. Europe Hypertension Drug Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Hypertension Drug Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Hypertension Drug Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Hypertension Drug Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Hypertension Drug Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Hypertension Drug Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Hypertension Drug Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Hypertension Drug Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Hypertension Drug Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Hypertension Drug Sales by Application (2021-2026) & (K Units)
Table 88. South America Hypertension Drug Sales by Country (2016-2021e) & (K Units)
Table 89. South America Hypertension Drug Sales by Country (2021-2026) & (K Units)
Table 90. South America Hypertension Drug Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Hypertension Drug Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Hypertension Drug Sales by Type (2016-2021e) & (K Units)
Table 93. South America Hypertension Drug Sales by Type (2021-2026) & (K Units)
Table 94. South America Hypertension Drug Sales by Application (2016-2021e) & (K Units)
Table 95. South America Hypertension Drug Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Hypertension Drug Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Hypertension Drug Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Hypertension Drug Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Hypertension Drug Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Hypertension Drug Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Hypertension Drug Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Hypertension Drug Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Hypertension Drug Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Hypertension Drug Typical Distributors
Table 107. Hypertension Drug Typical Customers
List of Figures
Figure 1. Hypertension Drug Picture
Figure 2. Global Hypertension Drug Sales Market Share by Type in 2020
Figure 3. Calcium Channel Blockers
Figure 4. Diuretics
Figure 5. Beta Blockers Vasodilators
Figure 6. Angiotensin Converting Enzyme Inhibitors
Figure 7. Alpha Blockers
Figure 8. Angiotensin Receptor Blockers
Figure 9. Renin Inhibitors
Figure 10. Global Hypertension Drug Sales Market Share by Application in 2020
Figure 11. Hospital
Figure 12. Private Clinic
Figure 13. Others
Figure 14. Global Hypertension Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 15. Global Hypertension Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Hypertension Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Hypertension Drug Sales (2016-2026) & (K Units)
Figure 36. Global Hypertension Drug Production Capacity (2016-2026) & (K Units)
Figure 37. Global Hypertension Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Hypertension Drug Market Drivers
Figure 39. Hypertension Drug Market Restraints
Figure 40. Hypertension Drug Market Trends
Figure 41. Global Hypertension Drug Sales Market Share by Manufacturer in 2020
Figure 42. Global Hypertension Drug Revenue Market Share by Manufacturer in 2020
Figure 43. Hypertension Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Hypertension Drug Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Hypertension Drug Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Hypertension Drug Sales Market Share by Region (2016-2026)
Figure 47. Global Hypertension Drug Revenue Market Share by Region (2016-2026)
Figure 48. North America Hypertension Drug Revenue (2016-2026) & (USD Million)
Figure 49. Europe Hypertension Drug Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Hypertension Drug Revenue (2016-2026) & (USD Million)
Figure 51. South America Hypertension Drug Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Hypertension Drug Revenue (2016-2026) & (USD Million)
Figure 53. Global Hypertension Drug Sales Market Share by Type (2016-2026)
Figure 54. Global Hypertension Drug Revenue Market Share by Type (2016-2026)
Figure 55. Global Hypertension Drug Price by Type (2016-2026) & (USD/Unit)
Figure 56. Global Hypertension Drug Sales Market Share by Application (2016-2026)
Figure 57. Global Hypertension Drug Revenue Market Share by Application (2016-2026)
Figure 58. Global Hypertension Drug Price by Application (2016-2026) & (USD/Unit)
Figure 59. North America Hypertension Drug Sales Market Share by Country (2016-2026)
Figure 60. North America Hypertension Drug Revenue Market Share by Country (2016-2026)
Figure 61. North America Hypertension Drug Sales Market Share by Type (2016-2026)
Figure 62. North America Hypertension Drug Sales Market Share by Application (2016-2026)
Figure 63. Europe Hypertension Drug Sales Market Share by Country (2016-2026)
Figure 64. Europe Hypertension Drug Revenue Market Share by Country (2016-2026)
Figure 65. Europe Hypertension Drug Sales Market Share by Type (2016-2026)
Figure 66. Europe Hypertension Drug Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Hypertension Drug Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Hypertension Drug Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Hypertension Drug Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Hypertension Drug Sales Market Share by Application (2016-2026)
Figure 71. South America Hypertension Drug Sales Market Share by Country (2016-2026)
Figure 72. South America Hypertension Drug Revenue Market Share by Country (2016-2026)
Figure 73. South America Hypertension Drug Sales Market Share by Type (2016-2026)
Figure 74. South America Hypertension Drug Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Hypertension Drug Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Hypertension Drug Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Hypertension Drug Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Hypertension Drug Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の高血圧・心不全治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypertension and Heart Failure Treatment Market The global Hypertension and Heart Failure Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…- 世界の肺動脈性肺高血圧症治療市場規模・現状・予測（2021年-2027年） Pulmonary arterial hypertension- commonly known as PAH- is characterized by increased pressure in the pulmonary arteries due to structural changes in blood vessel walls, aggregation of platelets and alteration of smooth muscle cell function- eventually elevating pressure in the pulmonary arteries re…
- 世界の肺動脈性肺高血圧症（PAH）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pulmonary Arterial Hypertension (PAH) Market The global Pulmonary Arterial Hypertension (PAH) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…
- 世界の高眼圧症治療市場規模・現状・予測（2021年-2027年） Ocular hypertension is caused by poor drainage of the fluid inside the eye. Essentially, this means that too much fluid enters the eye without being drained, causing high amount of pressure to build up. Market Analysis and Insights: Global Ocular Hypertension Treatment Market The global Ocular Hyper…
- 世界の慢性血栓塞栓性肺高血圧症（CTEPH）市場規模・現状・予測（2021年-2027年） Chronic thromboembolic pulmonary hypertension is observed to be one of the leading causes of severe pulmonary hypertension. It is a type of clinical condition in which pulmonary vascular resistance increases giving rise to pulmonary hypertension and progressive heart failure. According to World Heal…